Wagner Paul A.
Transaction: 07/01/2026
SELL
Change
-1,250
Price
Not reported
Filing
07/06/2026
Type
SELL
Forte Biosciences, Inc.
FBRX • Biotechnology
$76.99
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.83B
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 3.88Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:09 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$76.99
Change0.00%
Shares Out23.79M
Market Cap$1.83B
Enterprise Value$1.63B
52W Range9.91 - 77.20
Beta2.65
P/E-20.83
P/B9.96
P/FCF-60.01
EV/EBITDA-18.60
EV/FCF-53.50
Price$76.99
Change0.00%
Shares Out23.79M
Market Cap$1.83B
Enterprise Value$1.63B
52W Range9.91 - 77.20
Beta2.65
P/E-20.83
P/B9.96
P/FCF-60.01
EV/EBITDA-18.60
EV/FCF-53.50
Earnings Yield-4.80%
FCF Yield-1.67%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio3.88
Quick Ratio3.88
Revenue 5Y-100.00%
Target$77.00
Target Upside0.01%
Target Median$77.00
Target Range77.00 - 77.00
Volume1.14M
Avg Volume835.89K
EPS Surprise-0.08
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 3.88Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-04
71/100
Bullish
Bullish
3
Hold
4
Bearish
0
Price Target
2026-08-14
Low
$77.00
Mean
$77.00
Median
$77.00
High
$77.00
Insider Transactions
Recent executive and insider activity
Wagner Paul A.
Transaction: 07/01/2026
SELL
Change
-98
Price
$21.32
Filing
07/06/2026
Type
SELL
Riley Antony A
Transaction: 07/01/2026
SELL
Change
-375
Price
Not reported
Filing
07/06/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Wagner Paul A. | SELL | -1,250 | Not reported | 07/01/2026 | 07/06/2026 |
| Wagner Paul A. | SELL | -98 | $21.32 | 07/01/2026 | 07/06/2026 |
| Riley Antony A | SELL | -375 | Not reported | 07/01/2026 | 07/06/2026 |
| Riley Antony A | SELL | -134 | $21.32 | 07/01/2026 | 07/06/2026 |
| Wagner Paul A. | BUY | +500,000 | $17.15 | 06/16/2026 | 06/17/2026 |
| Riley Antony A | BUY | +22,000 | $17.15 | 06/16/2026 | 06/17/2026 |
| Kornfeld Steven | BUY | +18,353 | Not reported | 05/29/2026 | 06/02/2026 |
| Brun Scott C. | BUY | +18,353 | Not reported | 05/29/2026 | 06/02/2026 |
| GRYSKA DAVID W | BUY | +18,353 | Not reported | 05/29/2026 | 06/02/2026 |
| VINCENT RICHARD G | BUY | +18,353 | Not reported | 05/29/2026 | 06/02/2026 |
| Kapoor Shivpreet Singh | BUY | +18,353 | Not reported | 05/29/2026 | 06/02/2026 |
| Doberstein Stephen K | BUY | +18,353 | Not reported | 05/29/2026 | 06/02/2026 |
| Wagner Paul A. | SELL | -1,250 | Not reported | 04/01/2026 | 04/03/2026 |
| Wagner Paul A. | SELL | -98 | $24.86 | 04/01/2026 | 04/03/2026 |
| Riley Antony A | SELL | -375 | Not reported | 04/01/2026 | 04/03/2026 |
| Riley Antony A | SELL | -134 | $24.86 | 04/01/2026 | 04/03/2026 |
| Wagner Paul A. | BUY | +180,000 | Not reported | 01/12/2026 | 01/13/2026 |
| Wagner Paul A. | BUY | +270,000 | $29.66 | 01/12/2026 | 01/13/2026 |
| Riley Antony A | BUY | +60,000 | Not reported | 01/12/2026 | 01/13/2026 |
| Riley Antony A | BUY | +90,000 | $29.66 | 01/12/2026 | 01/13/2026 |